
浏览全部资源
扫码关注微信
400016 重庆, 重庆医科大学附属第一医院重症医学科
[ 张丹, E-mail:doctor_zhangdan@126.com ZHANG Dan, E-mail:doctor_zhangdan@126.com
收稿:2018-01-04,
修回:2018-02-02,
纸质出版:2018-08-15
移动端阅览
刘思佚, 曾燕, 刘疏柯, 等. 嗜铬粒蛋白A衍生多肽CHR抑制LPS诱导的永生化脑微血管内皮细胞高通透性[J]. 第三军医大学学报, 2018,40(15):1364-1369.
Siyi LIU, Yan ZENG, Shuke LIU, et al. Chromogranin A derived peptide CGA47-66 suppresses hyperpermeability of immortalized brain microvascular endothelial cells induced by lipopolysaccharide[J]. Journal of Third Military Medical University, 2018, 40(15): 1364-1369.
刘思佚, 曾燕, 刘疏柯, 等. 嗜铬粒蛋白A衍生多肽CHR抑制LPS诱导的永生化脑微血管内皮细胞高通透性[J]. 第三军医大学学报, 2018,40(15):1364-1369. DOI: 10.16016/j.1000-5404.201801036.
Siyi LIU, Yan ZENG, Shuke LIU, et al. Chromogranin A derived peptide CGA47-66 suppresses hyperpermeability of immortalized brain microvascular endothelial cells induced by lipopolysaccharide[J]. Journal of Third Military Medical University, 2018, 40(15): 1364-1369. DOI: 10.16016/j.1000-5404.201801036.
目的
2
探讨嗜铬粒蛋白A衍生多肽CHR(chromofungin)对LPS所诱导的永生化人脑微血管内皮细胞高通透性的影响。
方法
2
分别用LPS、CHR、CGA
4-16
作用于人脑微血管内皮细胞(human brain microvascular endothelial cells,HBMEC),用CCK8法检测不同浓度LPS刺激HBMEC细胞活力变化;EVOM法及Transwell小室法检测内皮细胞相对通透性;Western blot及RT-PCR法检测紧密连接蛋白(ZO-1和Claudin-5)的表达情况。
结果
2
与空白组相比,随着LPS浓度增加,HBMEC细胞的活性受到显著抑制(
P
<
0.05)。随着LPS作用时间延长,其细胞内紧密连接蛋白ZO-1、Claudin-5的表达逐渐下调,6 h后蛋白表达量降到最低(
P
<
0.05),12 h和24 h后其蛋白表达与6 h相比无明显差异。LPS作用下HBMEC单层细胞电阻值明显降低(
t
=-18.214,
P
<
0.001),细胞通透性显著升高(
t
=6.083,
P
=0.004),ZO-1、Claudin-5的蛋白和mRNA表达明显下调(
P
<
0.05),而CHR可显著改善上述变化。
结论
2
嗜铬粒蛋白A衍生多肽CHR能通过上调紧密连接相关蛋白的表达从而改善LPS所致的脑微血管内皮细胞高通透性。
Objective
2
To determine the effect of chromogranin A derived peptide CGA47-66 (chromofungin
CHR) on lipopolysaccharide (LPS) induced high permeability of immortalized brain microvascular endothelial cells.
Methods
2
Immortalized human brain microvascular endothelial cells (HBMEC) were exposed to LPS
CHR and CGA4-16 respectively. Cell counting kit-8 (CCK8) assay was used to detect the cell viability after inducement of different concentrations of LPS. The relative permeability of HBMEC cells was measured by a Transwell chamber system and epithelial voltmeter (EVOM). The expression levels of the tight junction protein ZO-1 and Claudin-5 were detected by Western blotting and quantitative real-time polymerase chain reaction (RT-PCR).
Results
2
Compared with the blank control cells
the viability of HBMEC cells was significantly inhibited with the increase concentrations of LPS (
P
<
0.05). With the elapse of time
LPS treatment decreased the expression levels of ZO-1 and Claudin-5 gradually
and the levels reached the lowest after 6 h (
P
<
0.05)
which having no significant difference with the levels at 12 or 24 h. LPS treatment also resulted in significantly decreased transendothelial electrical resistance (
t
=-18.214
P
<
0.001)
increased cell permeability (
t
=6.083
P
=0.004)
and down-regulation of ZO-1 and Claudin-5 at mRNA and protein levels (
P
<
0.05). However
CHR significantly attenuated the above changes.
Conclusion
2
CHR could attenuate the hyperperneability of human brain microvascular endothelial cells induced by LPS through up-regulating tight junction proteins.
GOFTON T E, YOUNG G B.Sepsis-associated encephalopathy[J]. Nat Rev Neurol, 2012, 8(10):557-566. DOI:10.1038/nrneurol.2012.183.
SEMMLER A, WIDMANN C N, OKULLA T, et al .Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors[J ] . J Neurol Neurosurg Psychiatry, 2013, 84(1):62-69. DOI:10.1136/jnnp-2012-302883.
WIDMANN C N, HENEKA M T.Long-term cerebral consequences of sepsis[J]. Lancet Neurol, 2014, 13(6):630-636. DOI:10.1016/s1474-4422(14)70017-1.
KUPERBERG S J, WADGAONKAR R. Sepsis-associated encephalopathy:the blood-brain barrier and the sphingolipid rheostat[J]. Front Immunol, 2017, 8:597. DOI:10.3389/fimmu.2017.00597.
ANNANE D, SHARSHAR T.Cognitive decline after sepsis[J]. Lancet Respir Med, 2015, 3(1):61-69.DOI:10.1016/s2213-2600(14)70246-2.
D'AMICO M A, GHINASSI B, IZZICUPOP, et al .Biological function and clinical relevance of chromogranin A and derived peptides[J ] . Endocr Connect, 2014, 3(2):R45-R54. DOI:10.1530/ec-14-0027.
CORTI A, FERRERO E.Chromogranin A and the endothelial barrier function[J]. Curr Med Chem, 2012, 19(24):4051-4058. DOI:10.2174/092986712802429975.
LUGARDON K, CHASSEROT-GOLAZ S, KIEFFER A E, et al .Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide[J ] . J Biol Chem, 2001, 276(38):35875-35882. DOI:10.1074/jbc.M104670200.
曾燕, 张丹, 姜丽萍, 等.嗜铬粒蛋白A衍生多肽CGA47-66抑制脓毒症小鼠血脑屏障通透性增加[J].中华危重病急救医学, 2016(2):122-126.DOI:10.3760/cma.j.issn.2095-4352.2016.02.008.
ZENG Y, ZHANG D, JIANG L P, et al . Chromogranin A derived peptide CGA47-66 inhibits hyper-permeability of blood brain barrier in mice with sepsis[J ] . Chin Crit Care Med, 2016(2):122-126.DOI:10.3760/cma.j.issn.2095-4352.2016.02.008.
PAPADOPOULOS M C, DAVIES D C, MOSS R F, et al .Pathophysiology of septic encephalopathy:a review[J ] . Crit Care Med, 2000, 28(8):3019-3024.
CHAUDHRY N, DUGGAL A K.Sepsis Associated Encephalopathy[J]. Adv Med, 2014, 2014:762320. DOI:10.1155/2014/762320.
SHARSHAR T, MAZERAUD A, VERDONK F, et al .Brain perfusion in sepsis or to resolve the macro part of the micro[J ] . Crit Care Med, 2014, 42(2):485-486. DOI:10.1097/ccm.0000000000000007.
SCHUETZ P, MVLLER B.The hypothalamic-pituitary-adrenal axis in critical illness[J]. Endocrinol Metab Clin North Am, 2006, 35(4):823-838. DOI:10.1016/j.ecl.2006.09.013.
ZHANG D, LAVAUX T, SAPIN R, et al .Serum concentration of chromogranin A at admission:an early biomarker of severity in critically ill patients[J ] . Ann Med, 2009, 41(1):38-44. DOI:10.1080/07853890802199791.
ZHANG D, LAVAUX T, VOEGELI A C, et al .Prognostic value of chromogranin A at admission in critically ill patients:a cohort study in a medical intensive care unit[J ] . Clin Chem, 2008, 54(9):1497-1503. DOI:10.1373/clinchem.2007.102442.
LIU J L, CHEN X Y, GU N N, et al .Correlation study on chromogranin A genetic polymorphism and prognosis of critically ill patients[J ] . J Crit Care, 2017, 39:137-142. DOI:10.1016/j.jcrc.2017.02.015.
ABBOTT N J, PATABENDIGE A A, DOLMAN D E, et al .Structure and function of the blood-brain barrier[J ] . Neurobiol Dis, 2010, 37(1):13-25. DOI:10.1016/j.nbd.2009.07.030.
STEED E, BALDA M S, MATTER K.Dynamics and functions of tight junctions[J]. Trends Cell Biol, 2010, 20(3):142-149. DOI:10.1016/j.tcb.2009.12.002.
BALDA M S, MATTER K.Tight junctions as regulators of tissue remodelling[J]. Curr Opin Cell Biol, 2016, 42:94-101. DOI:10.1016/j.ceb.2016.05.006.
VEDULA S R, LIM T S, KAUSALYA P J, et al . Biophysical approaches for studying the integrity and function of tight junctions[J ] . Mol Cell Biomech, 2005, 2(3):105-123.
古妮娜, 张丹, 罗丽, 等.嗜铬粒蛋白A衍生多肽CGA47-66抑制脓毒症血清所致血管内皮细胞高通透性的研究[J].中华危重病急救医学, 2013, 25(12):715-719.DOI:10.3760/cma.j.issn.2095-4352.2013.12.005.
GUN N, ZHANG D, LUO L, et al . AstudyofinhibitoryeffectofchromograninAderivedpeptideCGA47-66 onhyperpermeabilityof endotheliuminducedbyserumofsepticpatient[J ] . Chin Crit Care Med, 2013, 25(12):715-719. DOI:10.3760/cma.j.issn.2095-4352.2013.12.005.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621